Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-27 Sale |
2022-06-01 4:15 pm |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
367,360 | $0 | $0 | 0 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:23 pm |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
100,000 | $21.1 | $2,109,800 | 1,303,070 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 6:29 pm |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
270,000 | $21.82 | $5,890,487 | 367,360 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-23 Tax Withholding |
2025-02-25 4:37 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
14,067 | $0 | 2,421,193 (Direct) |
View |
| 2025-02-23 Exercise |
2025-02-25 4:37 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
57,413 | $0 | 2,421,193 (Direct) |
View |
| 2025-01-30 Option Award |
2025-02-03 7:22 pm |
2026-01-30 2035-01-30 |
PACIFIC BIOSCIENCES OF CALIFORNIA INC. | PACB | Smith Christopher M Director |
127,000 | $0 | 127,000 (Direct) |
View |
| 2024-05-11 Tax Withholding(A) |
2024-12-04 4:09 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
18,913 | $14.86 | 727,496 (Direct) |
View |
| 2024-05-11 Exercise(A) |
2024-12-04 4:09 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
48,063 | $0 | 727,496 (Direct) |
View |
| 2024-08-15 Tax Withholding |
2024-08-19 4:19 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
33,130 | $0 | 2,483,323 (Direct) |
View |
| 2024-05-11 Tax Withholding |
2024-05-14 9:39 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
18,913 | $14.86 | 2,516,453 (Direct) |
View |
| 2024-05-11 Exercise |
2024-05-14 9:39 pm |
N/A N/A |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
48,063 | $0 | 2,516,453 (Direct) |
View |
| 2024-02-23 Option Award |
2024-02-27 4:28 pm |
N/A 2034-02-23 |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
632,419 | $0 | 2,487,303 (Direct) |
View |
| 2023-06-06 Exercise |
2023-06-08 4:29 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
2,248 | $0 | 35,577 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:29 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
2,248 | $0 | 35,577 (Direct) |
View |
| 2023-05-27 Tax Withholding |
2023-05-31 4:05 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
1,225 | $85.54 | 33,329 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 8:21 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
2,898 | $0 | 2,898 (Direct) |
View |
| 2023-05-11 Option Award |
2023-05-15 5:07 pm |
N/A 2030-05-11 |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
558,221 | $0 | 1,854,884 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 7:13 pm |
N/A 2029-08-15 |
NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer |
1,296,663 | $0 | 1,296,663 (Direct) |
View |
| 2022-05-27 Option Award(A) |
2022-08-01 7:17 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
34,554 | $0 | 34,554 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-27 5:05 pm |
N/A 2032-06-22 |
Akouos Inc. | AKUS | Smith Christopher M Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-08 6:20 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
2,248 | $0 | 2,248 (Direct) |
View |
| 2022-05-27 Option Award |
2022-06-01 5:30 pm |
N/A 2029-12-20 |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
242,538 | $0 | 242,538 (Direct) |
View |
Ownership |
2022-06-01 4:59 pm |
N/A N/A |
QuidelOrtho Corp | QDEL | Smith Christopher M Director |
0 | $0 | 0 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:23 pm |
N/A N/A |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
100,000 | $12.56 | 1,303,070 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:23 pm |
N/A 2029-12-20 |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
100,000 | $0 | 1,303,070 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-25 4:35 pm |
N/A 2031-06-23 |
Akouos Inc. | AKUS | Smith Christopher M Director |
16,000 | $0 | 16,000 (Direct) |
View |
Ownership |
2021-01-27 9:10 pm |
N/A N/A |
Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO |
0 | $0 | 1,673,070 (Direct) |
View |
Ownership |
2020-06-25 7:11 pm |
N/A N/A |
Akouos Inc. | AKUS | Smith Christopher M Director |
0 | $0 | 39,030 (Direct) |
View |